Ayşe Tanatar Selected Research

Ayşe Tanatar Research Topics

5	Familial Mediterranean Fever (Periodic Disease) 01/2021 - 10/2019
3	Rheumatic Diseases (Rheumatism) 11/2022 - 05/2020
3	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2021 - 09/2019
2	COVID-19 11/2022 - 01/2022
2	Sacroiliitis 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2021 - 01/2020
1	Purpura 04/2021
1	Amyloidosis 01/2021
1	Arthritis (Polyarthritis) 01/2021
1	Erysipelas 01/2021
1	Erythema 01/2021
1	Fever (Fevers) 01/2021
1	Peritonitis 01/2021
1	Proteinuria 01/2021
1	Vasculitis (Vasculitides) 01/2021
1	Arthralgia (Joint Pain) 01/2021
1	Hypersensitivity (Allergy) 05/2020
1	Acne Vulgaris 01/2020
1	deficiency of adenosine deaminase 2 01/2020
1	Low Back Pain (Lumbago) 01/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020
1	Infections 01/2020
1	Intussusception 06/2019

5	Colchicine FDA LinkGeneric 01/2021 - 10/2019
2	VaccinesIBA 11/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2020
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2021 - 01/2021
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2021 - 01/2020
2	SteroidsIBA 05/2020 - 06/2019
1	mRNA VaccinesIBA 11/2022
1	BNT162 VaccineIBA 11/2022
1	COVID-19 VaccinesIBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2021
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2021
1	Pharmaceutical PreparationsIBA 05/2020
1	Adenosine DeaminaseIBA 01/2020
1	Isotretinoin (Accutane)FDA LinkGeneric 01/2020
1	Leflunomide (Arava)FDA LinkGeneric 09/2019

1	Therapeutics 05/2020